An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma

Ooi, Aikseng, Wong, Jing-Chii, Petillo, David, Roossien, Douglas, Perrier-Trudova, Victoria, Whitten, Douglas, Min, Bernice Wong Hui, Tan, Min-Han +9 more·2011·Cancer Cell

DOI 10.1016/j.ccr.2011.08.024

Cited by (405)

Items 101–200 of 405

Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies
Yue Zhao, Qiongzhu Dong, Jiahui Li, Kaili Zhang, Jie Qin, Jiangang Zhao, Qiye Sun, Zhefang Wang, Thomas Wartmann, Karl Walter Jauch et al. · 2018 · Seminars in Cancer Biology
Integrative clinical and molecular characterization of translocation renal cell carcinoma
Ziad Bakouny, Ananthan Sadagopan, Praful Kumar Ravi, Nebiyou Y. Metaferia, Jiao Li, Shatha AbuHammad, Stephen Tang, Thomas Denize, Emma R. Garner, Xin Yuan Gao et al. · 2022 · Cell Reports
Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Antoinette van Weverwijk, Nikos Koundouros, Marjan Iravani, Matthew Ashenden, Qiong Gao, George Poulogiannis, Ute Jungwirth, Clare M. Isacke · 2019 · Nature Communications
Alterations of metabolic genes and metabolites in cancer
Eric Karl Oermann, Jing Wu, Kun‐Liang Guan, Yue Xiong · 2012 · Seminars in Cell and Developmental Biology
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Nicole F. Villeneuve, Wang Tian, Tongde Wu, Zheng Sun, Alexandria Lau, Eli Chapman, Deyu Fang, Donna D. Zhang · 2013 · Molecular Cell
Genetic alterations in Krebs cycle and its impact on cancer pathogenesis
Karishma Sajnani, Farhadul Islam, Robert Anthony Smith, Vinod Gopalan, Alfred King-yin Lam · 2017 · Biochimie
Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights
Maria Isabel Carlo, A. Ari Hakimi, Grant Duncan Stewart, Gennady Bratslavsky, James Brugarolas, Ying‐Bei Chen, William Marston Linehan, Eamonn Richard Maher, Maria J. Merino, Kenneth Offit et al. · 2019 · European Urology
The role of natural products in revealing NRF2 function
Donna D. Zhang, Eli Chapman · 2020 · Natural Product Reports
Keap1 as the redox sensor of the antioxidant response
Virve Sihvola, Anna–Liisa Levonen · 2016 · Archives of Biochemistry and Biophysics
Mitochondrial dysfunctions in cancer: Genetic defects and oncogenic signaling impinging on TCA cycle activity
Enrico Desideri, Rolando Vegliante, Maria Rosa Ciriolo · 2014 · Cancer Letters
Mitochondrial metabolism-mediated redox regulation in cancer progression
Austin C. Boese, Sumin Kang · 2021 · Redox Biology
Profiling metabolic networks to study cancer metabolism
Karsten Hiller, Christian M. Metallo · 2012 · Current Opinion in Biotechnology
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
Michael John Kerins, John Milligan, James Akira Wohlschlegel, Aikseng Ooi · 2018 · Cancer Science
Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
Paolo Ettore Porporato, Valéry L. Payen, Bjorn Baselet, Pierre Sonveaux · 2015 · Cellular and Molecular Life Sciences
Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
Zheng, Liang, MacKenzie, Elaine D, Karim, Saadia A, Hedley, Ann, Blyth, Karen, Kalna, Gabriela, Watson, David G, Szlosarek, Peter, Frezza, Christian, Gottlieb, Eyal · 2013 · Cancer & Metabolism
The KEAP1-NRF2 System and Neurodegenerative Diseases
Akira Uruno, Masayuki P. Yamamoto · 2023 · Antioxidants and Redox Signaling
Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer
Carole Sourbier, Christopher J. Ricketts, Shingo Matsumoto, Daniel R. Crooks, Pei‐Jyun Liao, Philip Z. Mannes, Youfeng Yang, Ming-Hui Wei, Gaurav K. Srivastava, Sanchari Ghosh et al. · 2014 · Cancer Cell
Dimethyl Fumarate and Monomethyl Fumarate Promote Post-Ischemic Recovery in Mice
Yang Yao, Weimin Miao, Zhijia Liu, Wei Han, Kaibin Shi, Yi Shen, Handong Li, Qiang Liu, Ying Fu, DeRen Huang et al. · 2016 · Translational Stroke Research
The Metabolic Alterations of Cancer Cells
Marco Sciacovelli, Edoardo Gaude, Mika Hilvo, Christian Frezza · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
Succination of Keap1 and Activation of Nrf2-Dependent Antioxidant Pathways in FH-Deficient Papillary Renal Cell Carcinoma Type 2
Lisa N. Kinch, Nick V. Grishin, James Brugarolas · 2011 · Cancer Cell
Metabolic dysregulation in monogenic disorders and cancer — finding method in madness
Erez, Ayelet, DeBerardinis, Ralph J. · 2015 · Nature Reviews Cancer
New Strategies in Renal Cell Carcinoma: Targeting the Genetic and Metabolic Basis of Disease
Ramaprasad Srinivasan, Christopher J. Ricketts, Carole Sourbier, William Marston Linehan · 2015 · Clinical Cancer Research
Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis
Rola Saleeb, Fadi Brimo, Mina S. Farag, Alexis Rompré‐Brodeur, Fabio Rotondo, Vidya Beharry, Samantha Jane Wala, Pamela J. Plant, Michelle R. Downes, Kenneth Tony Pace et al. · 2017 · The American Journal of Surgical Pathology
Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
Youfeng Yang, Andrew N. Lane, Christopher J. Ricketts, Carole Sourbier, Ming-Hui Wei, Brian M. Shuch, Lisa S. Pike, Min Wu, Tracey Ann Rouault, László G. Boros et al. · 2013 · PLoS ONE
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
Yi Xiao, David Meierhofer · 2019 · International Journal of Molecular Sciences
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
Matej Sova, Luciano Saso · 2018 · Drug Design Development and Therapy
A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia
Adam, Julie, Yang, Ming, Bauerschmidt, Christina, Kitagawa, Mitsuhiro, O’Flaherty, Linda, Maheswaran, Pratheesh, Özkan, Gizem, Sahgal, Natasha, Baban, Dilair, Kato, Keiko et al. · 2013 · Cell Reports
The intricacies of NRF2 regulation in cancer
Cody J. Schmidlin, Aryatara Shakya, Matthew B. Dodson, Eli Chapman, Donna D. Zhang · 2021 · Seminars in Cancer Biology
The Tumorigenic Roles of the Cellular REDOX Regulatory Systems
Stéphanie A. Castaldo, Joana Raquel Freitas, Nadine Vasconcelos Conchinha, Patrícia A. Madureira · 2015 · Oxidative Medicine and Cellular Longevity
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Byung-Jin Jung, Hwan-Sic Yoo, Sooyoung Shin, Young‐Joon Park, Sang‐Min Jeon · 2017 · Biomolecules & Therapeutics
Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
Keito Okazaki, Hayato Anzawa, Zun Liu, Nao Ota, Hiroshi Kitamura, Yoshiaki Onodera, Md. Morshedul Alam, Daisuke Matsumaru, Takuma Suzuki, Fumiki Katsuoka et al. · 2020 · Nature Communications
Dimethyl fumarate attenuates cerebral edema formation by protecting the blood–brain barrier integrity
Reiner Kunze, Andrés A. Urrutia, Angelika Hoffmann, Hui Liu, Xavier Helluy, Mirko Pham, Stefan Reischl, Thomas Korff, Hugo H. Marti · 2015 · Experimental Neurology
An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma
Andrew C. Nelson, Nischalan Pillay, Stephen R Henderson, Nadège Presneau, Roberto Tirabosco, Dina Halai, Fitim Berisha, Paul Flicek, Derek L. Stemple, Claudio D. Stern et al. · 2012 · The Journal of Pathology
Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
Katarína Smolková, Edit Mikó, Tündé Kovàcs, Alberto Leguina‐Ruzzi, Adrienn Sipos, Péter Bai · 2020 · Antioxidants and Redox Signaling
Metabolic alterations in renal cell carcinoma
Francesco Massari, Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, Francesco Piva, Alessandra Modena, Davide Bimbatti, Emanuela Fantinel, Daniele Santini, Liang Cheng C et al. · 2015 · Cancer Treatment Reviews
Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
Petros A. Tyrakis, Marie E. Yurkovich, Marco Sciacovelli, Evangelia K. Papachristou, Hannah R. Bridges, Edoardo Gaude, Alexander Schreiner, Clive S. D’Santos, Judy Hirst, Juan Ramon Hernandez-Fernaud et al. · 2017 · Cell Reports
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals
Claire Forde, Derek Lim, Yousef Alwan, George J. Burghel, Laura Butland, Ruth Cleaver, Abhijit Dixit, D. Gareth Evans, Helen Hanson, Fiona I. Lalloo et al. · 2019 · European Urology Oncology
The Role of AKR1B10 in Physiology and Pathophysiology
Satoshi Endo, Toshiyuki Matsunaga, Toru Nishinaka · 2021 · Metabolites
Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis
John D. Hayes, Sharadha Dayalan Naidu, Albena T. Dinkova‐Kostova · 2025 · Trends in Biochemical Sciences
Aerobic glycolysis: a novel target in kidney cancer
Brian M. Shuch, William Marston Linehan, Ramaprasad Srinivasan · 2013 · Expert Review of Anticancer Therapy
Dysregulation of the Keap1–Nrf2 pathway in cancer
Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi, Anna–Liisa Levonen · 2015 · Biochemical Society Transactions
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
Nadine Keleku-Lukwete, Mikiko Suzuki, Masayuki P. Yamamoto · 2017 · Antioxidants and Redox Signaling
Rare insights into cancer biology
Julie Adam, Mingming Yang, Tomoyoshi Soga, Patrick J. Pollard · 2013 · Oncogene
Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer
Feilong Chen, Mei Xiao, Shaofan Hu, Meng Wang · 2024 · Frontiers in Oncology
Genetically-defined metabolic reprogramming in cancer
Andrew R. Mullen, Ralph J. DeBerardinis · 2012 · Trends in Endocrinology and Metabolism
Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients
Greene, Christopher J., Attwood, Kristopher, Sharma, Nitika J., Gross, Kenneth W., Smith, Gary J., Xu, Bo, Kauffman, Eric C. · 2017 · Oncotarget
Unsuspected task for an old team: Succinate, fumarate and other Krebs cycle acids in metabolic remodeling
Paule Bénit, Éric Letouzé, Malgorzata Rak, Laëtitia Aubry, Nelly Burnichon, Judith Favier, Anne‐Paule Gimenez‐Roqueplo, Pierre Rustin · 2014 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Mitochondrial dysfunction in cancer chemoresistance
Nicoletta Guaragnella, Sergio Giannattasio, Loredana Moro · 2014 · Biochemical Pharmacology
Succinate: A New Epigenetic Hacker
Ming Hui Yang, Patrick J. Pollard · 2013 · Cancer Cell
The succinated proteome
Eric D. Merkley, Thomas Metz, Richard D. Smith, John Baynes, Norma Frizzell · 2013 · Mass Spectrometry Reviews
NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis
Holly Robertson, Albena T. Dinkova‐Kostova, John D. Hayes · 2020 · Cancers
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase–deficient renal cancer
Daniel R. Crooks, Nunziata Maio, Martin Lang, Christopher J. Ricketts, Cathy D. Vocke, Sandeep Gurram, Sevilay Turan, Yunyoung Kim, Geetha Mariah Cawthon, Ferri Sohelian et al. · 2021 · Science Signaling
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Aikseng Ooi · 2019 · Seminars in Cancer Biology
Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications
Hsin‐Yi Chen, Ruey‐Hwa Chen · 2016 · Frontiers in Oncology
Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?
Giulio Laurenti, Daniel A. Tennant · 2016 · Biochemical Society Transactions
Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma.
Xin Ge, Meng-Die Li, Jian-Xin Yin, Zhu-Mei Shi, Yao Fu, Ning-Wei Zhao, Hongshan Chen, Longxiyu Meng, Xinjian Li, Zhibin Hu et al. · 2022 · Molecules and Cells
Metabolism of Kidney Cancer: From the Lab to Clinical Practice
Sunil Sudarshan, Jose Antonio Karam, James Brugarolas, Robert Houston Thompson, Robert G. Uzzo, Brian I. Rini, Vitaly Margulis, Jean‐Jacques Patard, Bernard J. Escudier, William Marston Linehan · 2012 · European Urology
Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
Maria Brüggemann, Arabella Gromes, Mirjam Poss, Doris H. Schmidt, Niklas Klümper, Yuri Tolkach, Dimo Dietrich, Glen Kristiansen, Stefan C Müller, Jörg Ellinger · 2017 · Translational Oncology
Metabolic determinants of tumour initiation
Julia S. Brunner, Lydia W.S. Finley · 2022 · Nature Reviews Endocrinology
The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism
Sae Bom Lee, Brianna N. Sellers, Gina M. DeNicola · 2017 · Antioxidants and Redox Signaling
Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma
Marta Melis, Giacomo Diaz, David Erwin Kleiner, Fausto Zamboni, Juraj Kabát, Jinping Lai, Giulia Mogavero, Ashley B. Tice, Ronald E. Engle, Steven Becker et al. · 2014 · Journal of Translational Medicine
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, Zhe Zhang, Qi Zhang, Tingbo Liang · 2024 · Antioxidants
Acetoacetate Accelerates Muscle Regeneration and Ameliorates Muscular Dystrophy in Mice
Xiaoting Zou, Jiao Meng, Li Li, Wanhong Han, Changyin Li, Ran Zhong, Xuexia Miao, Jun Chao Cai, Yong Zhang, Dahai Zhu · 2015 · Journal of Biological Chemistry
Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation
Yuuki Yamaguchi, Hiroyuki Kanzaki, Yuta Katsumata, Kanako Itohiya, Sari Fukaya, Yutaka Miyamoto, Tsuyoshi Narimiya, Satoshi Wada, Yoshiki Nakamura · 2017 · Journal of Cellular and Molecular Medicine
Metabolic Pathways in Kidney Cancer: Current Therapies and Future Directions
W. Kimryn Rathmell, Jeffrey C. Rathmell, William Marston Linehan · 2018 · Journal of Clinical Oncology
Precision medicine from the renal cancer genome
Yasser Riazalhosseini, Mark G. Lathrop · 2016 · Nature Reviews Nephrology
Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
Sarah Schrödter, Martin Braun, Isabella Syring, Niklas Klümper, Mario Deng, Doris H. Schmidt, Sven Perner, Stefan C Müller, Jörg Ellinger · 2016 · Molecular Cancer
The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer
Warren Wu, Thales Y. Papagiannakopoulos · 2020 · Annual Review of Cancer Biology
Mito-Nuclear Communication by Mitochondrial Metabolites and Its Regulation by B-Vitamins
Joëlle J. E. Janssen, Sander Grefte, Jaap Keijer, Vincent C. J. de Boer · 2019 · Frontiers in Physiology
GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway
Jingjing Li, Qiujie Wang, Yi Yang, Chong Lei, Fan Yang, Li Liang, Chang Chen, Jie Lai Xia, Kai Wang, Ni Tang · 2019 · Journal of Experimental & Clinical Cancer Research
Nrf2 in early vascular ageing: Calcification, senescence and therapy
Samsul Arefin, Sarah J Buchanan, Sam Hobson, Julia L. Steinmetz, Shno Alsalhi, Paul G. Shiels, Karolina R. Kublickiene, Peter Stenvinkel · 2020 · Clinica Chimica Acta
Aldo-keto reductases are biomarkers of NRF2 activity and are co-ordinately overexpressed in non-small cell lung cancer
A Kenneth MacLeod, Lourdes Acosta-Jimenez, Philip John Coates, Michael J. McMahon, Frank A. Carey, Tadashi Honda, Colin J. Henderson, C. Roland Wolf · 2016 · British Journal of Cancer
Mitochondrial Retrograde Signalling and Metabolic Alterations in the Tumour Microenvironment
Dongki Yang, Jaehong Kim · 2019 · Cells
Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis
Ciric To, Carol S. Ringelberg, Darlene B. Royce, Charlotte R. Williams, Renee Risingsong, Michael B. Sporn, Karen T. Liby · 2015 · Carcinogenesis
Metabolic synthetic lethality in cancer therapy
Vincent Roberto Zecchini, Christian Frezza · 2016 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
The Oncometabolite Fumarate Promotes Pseudohypoxia Through Noncanonical Activation of NF-κB Signaling
Karthigayan Shanmugasundaram, Bijaya Nayak, Eun‐Hee Shim, Carolina Becker Livi, Karen L. Block, Sunil Sudarshan · 2014 · Journal of Biological Chemistry
Cholesterol and the development of clear-cell renal carcinoma
Harry A. Drabkin, Robert M. Gemmill · 2012 · Current Opinion in Pharmacology
Understanding the role of NRF2-regulated miRNAs in human malignancies
Niraj Shah, Stuart A. Rushworth, Megan Y. Murray, Kristian M. Bowles, David J. MacEwan · 2013 · Oncotarget
The Succinated Proteome of FH-Mutant Tumours
Ming Hui Yang, Nicola Ternette, Huizhong Su, Raliat Dabiri, Benedikt Mathias Kessler, Julie Adam, Bin Tean Teh, Patrick J. Pollard · 2014 · Metabolites
Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs
Federico Pio Fabrizio, Angelo Sparaneo, Domenico Trombetta, Lucia Anna Muscarella · 2018 · Oxidative Medicine and Cellular Longevity
Modulation of Nuclear Factor E2-related Factor-2 (Nrf2) Activation by the Stress Response Gene Immediate Early Response-3 (IER3) in Colonic Epithelial Cells
Imke Stachel, Claudia Geismann, Konrad Aden, Florian Deisinger, Philip C Rosenstiel, Stefan Schreiber, Susanne Sebens, Alexander Arlt, H. Schäfer · 2013 · Journal of Biological Chemistry
Overview of redox regulation by Keap1–Nrf2 system in toxicology and cancer
Mikiko Suzuki, Akihito Otsuki, Nadine Keleku-Lukwete, Masayuki P. Yamamoto · 2016 · Current Opinion in Toxicology
Hidden features: exploring the non-canonical functions of metabolic enzymes
Peiwei Huangyang, Marie Celeste Simon · 2018 · Disease Models & Mechanisms
FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer
Blake R. Wilde, Nishma Chakraborty, Nedas Matulionis, Stephanie Hernandez, Daiki Ueno, Michayla E. Gee, Edward D. Esplin, Karen Ouyang, Keith Nykamp, Brian M. Shuch et al. · 2023 · Cancer Discovery
Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes
Michael John Kerins, Ajay Amar Vashisht, Benjamin Xi-Tong Liang, Spencer Jordan Duckworth, Brandon John Praslicka, James Akira Wohlschlegel, Aikseng Ooi · 2017 · Molecular and Cellular Biology
Citric Acid Cycle Intermediates in Cardioprotection
Gábor Czibik, Violetta Steeples, Arash Yavari, Houman Ashrafian · 2014 · Circulation Cardiovascular Genetics
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC): A Contemporary Review and Practical Discussion of the Differential Diagnosis for HLRCC-Associated Renal Cell Carcinoma
Stephanie L. Skala, Saravana Mohan Dhanasekaran, Rohit Mehra · 2018 · Archives of Pathology & Laboratory Medicine
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Makiko Hayashi, Ayumi Kuga, Mikiko Suzuki, Harit Panda, Hiroshi Kitamura, Hozumi Motohashi, Masayuki P. Yamamoto · 2020 · Cancer Research
Oncometabolites at the crossroads of genetic, epigenetic and ecological alterations in cancer
Letizia Lanzetti · 2024 · Cell Death and Differentiation
The opposite prognostic effect of NDUFS1 and NDUFS8 in lung cancer reflects the oncojanus role of mitochondrial complex I
Chia‐Yi Su, Yu‐Chan Chang, Chih‐Jen Yang, Ming-Shyan Huang, Michael Hsiao · 2016 · Scientific Reports
The role of mitochondria in the oncogenic signal transduction
Christian Frezza · 2014 · The International Journal of Biochemistry & Cell Biology
Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance
Zahra Payandeh, Abbas Pirpour Tazehkand, Ghasem Barati, Farhad Pouremamali, Houman Kahroba, Behzad Baradaran, Nasser Samadi · 2020 · Biochimie
HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System
Anna M. Cyran, Anatoly Zhitkovich · 2022 · Chemical Research in Toxicology
Systematic Expression Analysis of Mitochondrial Complex I Identifies NDUFS1 as a Biomarker in Clear-Cell Renal-Cell Carcinoma
Jörg Ellinger, Mirjam Poss, Maria Brüggemann, Arabella Gromes, Doris H. Schmidt, Nadja Ellinger, Yuri Tolkach, Dimo Dietrich, Glen Kristiansen, Stefan C. Müller · 2016 · Clinical Genitourinary Cancer
Genetic mutations associated with lung cancer metastasis to the brain
Hashim M. Aljohani, Mohamed Aittaleb, John Michael Furgason, Peter Amaya, Ayham Deeb, Jeffery J. Chalmers, El Mustapha Bahassi · 2018 · Mutagenesis
Redox balance and autophagy regulation in cancer progression and their therapeutic perspective
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, Baseerat Hamza, Fayaz Ahmad Malik · 2022 · Medical Oncology
Post-translational modifications of Keap1: the state of the art
Yunjia Song, Ying Qu, Caiyun Mao, Rong Zhang, Deyou Jiang, Xütao Sun · 2024 · Frontiers in Cell and Developmental Biology
Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies
Valentina Schiavoni, Monica Emanuelli, Giulio Milanese, Andrea Benedetto Galosi, Veronica Pompei, Eleonora Salvolini, Roberto Campagna · 2024 · International Journal of Molecular Sciences
S-lactoyl modification of KEAP1 by a reactive glycolytic metabolite activates NRF2 signaling
Yeonjin Ko, Mannkyu Hong, Seungbeom Lee, Manoj Kumar, Lara H. Ibrahim, Kayla Nutsch, Caroline R. Stanton, Phillip Sondermann, Braddock A. Sandoval, Maya L. Bulos et al. · 2023 · Proceedings of the National Academy of Sciences
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso · 2021 · Antioxidants and Redox Signaling